These risks, which are in the drug labels for their approved uses, may be mitigated when health care professionals closely screen and supervise these patients such as in a hospital setting or a clinical trial, as indicated in the Emergency Use Authorization( EUA) for these drugs to treat COVID-19....
The EUA requires that fact sheets with important information about using these drugs in treating COVID-19, including the known risks and drug interactions, as well as appropriate screening and moni
综合
美国有线电视-特朗普新闻
2020-04-24 00:00:00.0